{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:39:25Z","timestamp":1790361565093,"version":"4.1.0"},"reference-count":19,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.37438","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:12:48Z","timestamp":1613693568000},"page":"e2037438","source":"Crossref","is-referenced-by-count":49,"title":["Clinical Characteristics and Outcomes Associated With Oral Anticoagulant Use Among Patients Hospitalized With Intracerebral Hemorrhage"],"prefix":"10.1001","volume":"4","author":[{"given":"Ying","family":"Xian","sequence":"first","affiliation":[{"name":"The Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"},{"name":"Department of Neurology, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaiqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Inohara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine, Tokyo, Japan"},{"name":"Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grau-Sepulveda","sequence":"additional","affiliation":[{"name":"The Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland A.","family":"Matsouaka","sequence":"additional","affiliation":[{"name":"The Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"},{"name":"Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[{"name":"The Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Piccini","sequence":"additional","affiliation":[{"name":"The Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric E.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Sheth","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California at Los Angeles, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee H.","family":"Schwamm","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"issue":"9921","key":"zoi201122r1","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"zoi201122r2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation.","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi201122r3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"zoi201122r4","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation.","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"issue":"22","key":"zoi201122r5","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1182\/blood-2016-08-731638","article-title":"Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy.","volume":"129","author":"Lopes","year":"2017","journal-title":"Blood"},{"issue":"5","key":"zoi201122r6","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1161\/STROKEAHA.113.004506","article-title":"Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation.","volume":"45","author":"Hankey","year":"2014","journal-title":"Stroke"},{"issue":"8","key":"zoi201122r7","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1161\/STROKEAHA.114.006025","article-title":"Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.","volume":"45","author":"Giugliano","year":"2014","journal-title":"Stroke"},{"issue":"9","key":"zoi201122r8","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1161\/STROKEAHA.114.006661","article-title":"Characteristics of intracerebral hemorrhage during rivaroxaban treatment: comparison with those during warfarin.","volume":"45","author":"Hagii","year":"2014","journal-title":"Stroke"},{"issue":"5","key":"zoi201122r9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jama.2017.21917","article-title":"Association of intracerebral hemorrhage among patients taking non-vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital mortality.","volume":"319","author":"Inohara","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"zoi201122r10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1161\/CIRCOUTCOMES.109.921858","article-title":"Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke.","volume":"3","author":"Fonarow","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"zoi201122r11","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ahj.2011.12.012","article-title":"Data quality in the American Heart Association Get With The Guidelines-Stroke (GWTG-Stroke): results from a national data validation audit.","volume":"163","author":"Xian","year":"2012","journal-title":"Am Heart J"},{"issue":"10","key":"zoi201122r12","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/jama.2017.1371","article-title":"Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation.","volume":"317","author":"Xian","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"zoi201122r13","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons.","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"issue":"38","key":"zoi201122r14","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS.","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"4","key":"zoi201122r15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1212\/WNL.0000000000002310","article-title":"Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type.","volume":"86","author":"Wilson","year":"2016","journal-title":"Neurology"},{"key":"zoi201122r16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jocn.2018.10.102","article-title":"Intracerebral hemorrhage associated with warfarin versus non-vitamin K antagonist oral anticoagulants in Asian patients.","volume":"61","author":"Woo","year":"2019","journal-title":"J Clin Neurosci"},{"issue":"21","key":"zoi201122r17","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1161\/CIRCULATIONAHA.120.045769","article-title":"Factor Xa inhibitor-related intracranial hemorrhage: results from a multicenter, observational cohort receiving prothrombin complex concentrates.","volume":"141","author":"Panos","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"zoi201122r18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/2396987319849763","article-title":"European Stroke Organisation guideline on reversal of oral anticoagulants in acute intracerebral haemorrhage.","volume":"4","author":"Christensen","year":"2019","journal-title":"Eur Stroke J"},{"issue":"1","key":"zoi201122r19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12028-015-0222-x","article-title":"Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine.","volume":"24","author":"Frontera","year":"2016","journal-title":"Neurocrit Care"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2776519\/xian_2021_oi_201122_1612883607.85265.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:12:50Z","timestamp":1613693570000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2776519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.37438","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,16]]}}}